全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

0.03%他克莫司软膏主动维持治疗儿童和青少年慢性唇炎的疗效及安全性评价
Clinical Efficacy and Safety of Proactive Therapy with 0.03% Tacrolimus for Chronic Cheilitis in Children and Adolescents.

DOI: 10.13701/j.cnki.kqyxyj.2017.07.015

Keywords: 慢性唇炎,主动维持疗法,他克莫司软膏,
Chronic cheilitis
, Proactive therapy,Tacrolimus ointment

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要 目的:采用主动维持疗法,观察0.03%他克莫司软膏治疗儿童和青少年慢性唇炎的疗效,并对其安全性进行评价。方法:本试验共分为2个阶段:治疗阶段(第一阶段)与主动维持阶段(第二阶段)。在试验第一阶段,将40例慢性唇炎患者随机分为2组,试验组25例,对照组15例。试验组首先湿敷复方氯己定溶液,再涂用0.03%他克莫司软膏。对照组仅湿敷复方氯己定,每天2次,连续2周。试验组中痊愈和显效的患者进入第二阶段,并随机分配至试验组或对照组,试验组采用间歇性主动维持疗法,对照组在本阶段不进行间歇维持治疗,如病损复发时采用常规治疗,两组的观察期均为6个月。结果:第一阶段,他克莫司组痊愈21例,显效3例,总有效率为96%,明显高于对照组(60%),差异有统计学意义(P<0.05)第一阶段试验结束后,试验组24例患者进入第二阶段,并随机分为试验组和对照组各12例。第二阶段试验组有效率为100%,对照组的有效率为91.7%,差异无统计学意义。试验组首次出现复发的时间均值为(95.5±9.2) d,对照组均值为(26.6±10.0) d,差异具有统计学意义。试验组患者复发率16.7%明显低于对照组患者58.3%,差异有统计学意义(P<0.05)。结论: 0.03%他克莫司软膏采用主动维持疗法能显著降低儿童和青少年慢性唇炎的复发,疗效好且安全

References

[1]  陈谦明.口腔黏膜病学[M].第4版.北京,人民卫生出版社,2012∶143
[2]  黄跃深,万建蹟,刘广仁,等.0.1%他克莫司软膏治疗唇炎的临床疗效观察[J].中国当代医药,2015,22(3)∶113-117
[3]  Wollenberg A, Reitamo S, Atzori F et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment [J]. Allergy, 2008, 63∶742-750
[4]  Nordal EJ,Guleng GE,Rnnevig JR.Treatment of vitiligo with narrowband-UVB ( TL01) combined with tacrolimus ointment( 0.1%) vs.placebo ointment,a randomized right /left double-blind comparative study [J]. J Eur Acad Dermatol Venereol, 2011,25(12)∶1440-1443
[5]  李娟,黄婷,薛雯,等.牙周基础治疗联合局部药物治疗对糜烂性口腔扁平苔藓的临床效果观察[J].口腔疾病防治,2016,24(3)∶162-165
[6]  Fukuie T, Hirakawa S, Narita M, et al. Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator-blinded, controlled study [J]. J Dermatol, 2016, 43(11)∶1283-1292
[7]  祝磊,焦静.0.03%他克莫司软膏治疗口腔糜烂型扁平苔藓的疗效观察[J].口腔医学研究,2012,28(8)∶803-807
[8]  Van Der Meer JB, Glazenburg EJ, Mulder PG, et al.The management of moderate to severe atopic dermatitis in adults with epical fluticasone propionate. The Netherlands adults atopic dermatitis study group [J]. Br J Dermatol. 1999, 140∶1114-1121
[9]  黄玉成,李天举,李雅琼等.0.1%他克莫司软膏联合多磺酸粘多糖乳膏治疗剥脱性唇炎的临床观察[J].临床皮肤科杂志,2016,45(8)∶607-608
[10]  蒋李懿,罗刚,殷操.他克莫司软膏治疗糜烂型口腔扁平苔藓的短期疗效观察[J].广东牙病防治,2009,17(10)∶476-478
[11]  谷芳,曾光明,周敏,等.三种治疗慢性唇炎的方法比较[J].华西口腔医学杂志,1998,16(3)∶281-282
[12]  Fukuie T, Nomura I, Horimukai K et al. Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis [J]. Br J Dermatol, 2010, 163∶1127-1129
[13]  Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population [J]. Pediatrics, 2008, 122∶812- 824
[14]  曾宪涛,姚馨蕙,耿发云.他克莫司软膏加口炎清颗粒治疗糜烂型口腔扁平苔藓的短期疗效评价[J].广东牙病防治,2011,19(10)∶528-530
[15]  Wang X, Zhang L, Luo J, et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial [J]. J Clin Pharmacol. 2015, 55(11)∶1221-1228

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133